ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

DXSP DXS International Plc

1.55
0.00 (0.00%)
29 Nov 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type Share ISIN Share Description
DXS International Plc AQSE:DXSP Aquis Stock Exchange Ordinary Share GB00B2Q6HZ92
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.55 1.00 2.00 1.55 1.50 1.55 0.00 16:29:54
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Statement re: Further NHS Accreditation

25/04/2023 7:00am

GlobeNewswire Inc.


DXS (AQSE:DXSP)
Historical Stock Chart


From Nov 2022 to Nov 2024

Click Here for more DXS Charts.
Statement re: Further NHS Accreditation

DXS INTERNATIONAL PLC

(AQSE: DXSP)

Statement Re:  Further NHS Accreditation

DXS International, the digital clinical decision support company, is pleased to announce that on Friday 14 April it received NHS Accreditation for the NHS IM1 Pairing Integration API which provides read and write access to GP patient data throughout the UK.

This important achievement alleviates DXS’ dependency on using the existing commercial integrations provided by the three leading suppliers of primary care patient record systems in the UK. The development will also significantly enhance DXS’ ability to deliver its new ExpertCare Hypertension solution to users such as GPs, nurses and pharmacists throughout the UK, faster, better and more cost effectively.

This 18-month development initiative included building the foundation component of a new cloud based Aios platform which will significantly speed up deployment of various DXS products, automate user workflows and reduce support overhead.

David Immelman, DXS CEO, said “This is an exciting step forward, especially as DXS ExpertCare can help the NHS achieve its new target in England for GP practices to get controlled blood pressure up from 60% to 77% of the 8.5 million hypertensive patients in England which can save thousands of strokes and heart attacks.”

The Directors of DXS International plc accept responsibility for this announcement.

Contacts:

David Immelman      (Chief Executive)DXS International plc01252 719800david@dxs-systems.com
https://www.dxs-systems.co.uk 

Corporate Advisor  
City & Merchant David Papworth 020 7101 7676 

Corporate Broker  
Hybridan LLPClaire Louise Noyce 020 3764 2341 

Notes to Editors

About DXS:

DXS International presents up to date treatment guidelines and recommendations, from Clinical Commissioning Groups and other trusted NHS sources, to doctors, nurses and pharmacists in their workflow and during the patient consultation. This effective clinical decision support ultimately translates to improved healthcare outcomes delivered more cost effectively and which should significantly contribute towards the NHS achieving its projected efficiency savings.

1 Year DXS Chart

1 Year DXS Chart

1 Month DXS Chart

1 Month DXS Chart

Your Recent History

Delayed Upgrade Clock